KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non-Current Assets (2016 - 2025)

Sarepta Therapeutics has reported Other Non-Current Assets over the past 16 years, most recently at $5.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 354.47% year-over-year to $5.2 million; the TTM value through Dec 2025 reached $5.2 million, up 354.47%, while the annual FY2025 figure was $5.2 million, 354.47% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $5.2 million at Sarepta Therapeutics, up from $4.2 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $278.6 million in Q1 2022 and troughed at $1.1 million in Q4 2024.
  • A 5-year average of $68.9 million and a median of $12.1 million in 2023 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: soared 8020.03% in 2022 and later tumbled 99.17% in 2024.
  • Year by year, Other Non-Current Assets stood at $2.0 million in 2021, then soared by 8020.03% to $163.0 million in 2022, then dropped by 16.08% to $136.8 million in 2023, then tumbled by 99.17% to $1.1 million in 2024, then skyrocketed by 354.47% to $5.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for SRPT at $5.2 million in Q4 2025, $4.2 million in Q3 2025, and $83.1 million in Q2 2025.